|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008479,
umls-concept:C0027627,
umls-concept:C0030705,
umls-concept:C0034897,
umls-concept:C0035647,
umls-concept:C0042071,
umls-concept:C0205217,
umls-concept:C0332281,
umls-concept:C0699919,
umls-concept:C1514559,
umls-concept:C1522670
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2000-9-19
|
|
pubmed:abstractText |
Deregulation of the cellular protease network has been shown to be responsible for aggressive clinical behavior in several common human malignancies. In the current study, the authors evaluated the expression patterns of proteases in patients with chondrosarcoma of bone and correlated these patterns with clinical outcome.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CTSL1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cathepsin B,
http://linkedlifedata.com/resource/pubmed/chemical/Cathepsin L,
http://linkedlifedata.com/resource/pubmed/chemical/Cathepsins,
http://linkedlifedata.com/resource/pubmed/chemical/Cysteine Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
995-1003
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:10964329-Adult,
pubmed-meshheading:10964329-Bone Neoplasms,
pubmed-meshheading:10964329-Cathepsin B,
pubmed-meshheading:10964329-Cathepsin L,
pubmed-meshheading:10964329-Cathepsins,
pubmed-meshheading:10964329-Chondrosarcoma,
pubmed-meshheading:10964329-Cohort Studies,
pubmed-meshheading:10964329-Cysteine Endopeptidases,
pubmed-meshheading:10964329-Endopeptidases,
pubmed-meshheading:10964329-Female,
pubmed-meshheading:10964329-Follow-Up Studies,
pubmed-meshheading:10964329-Humans,
pubmed-meshheading:10964329-Immunohistochemistry,
pubmed-meshheading:10964329-Male,
pubmed-meshheading:10964329-Matrix Metalloproteinase 1,
pubmed-meshheading:10964329-Middle Aged,
pubmed-meshheading:10964329-Neoplasm Staging,
pubmed-meshheading:10964329-Prognosis,
pubmed-meshheading:10964329-Recurrence,
pubmed-meshheading:10964329-Risk Factors,
pubmed-meshheading:10964329-Survival Analysis,
pubmed-meshheading:10964329-Tumor Markers, Biological,
pubmed-meshheading:10964329-Urokinase-Type Plasminogen Activator
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma.
|
|
pubmed:affiliation |
Department of Pathology, Otto-von-Guericke University, Magdeburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
